BRCA1 Antikörper (AA 1314-1600, AA 1314-1864)
-
- Target Alle BRCA1 Antikörper anzeigen
- BRCA1 (Breast Cancer 1 (BRCA1))
-
Bindungsspezifität
- AA 1314-1600, AA 1314-1864
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser BRCA1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunofluorescence (IF), Immunoprecipitation (IP), Flow Cytometry (FACS), Immunocytochemistry (ICC)
- Spezifität
- Reacts with human BRCA1 protein
- Aufreinigung
- Purified (protein G)
- Immunogen
- Human BRCA1 between residues 1314-1864. The epitope recognized is found between amino acids 1314-1600
- Klon
- RAY
- Isotyp
- IgG2a
- Top Product
- Discover our top product BRCA1 Primärantikörper
-
anti-Breast Cancer 1 (BRCA1) (AA 120-220) antibody
BRCA1 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 1 (BRCA1) (AA 19-83) antibodyBRCA1 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 1 (BRCA1) (pSer1423) antibodyBRCA1 Reaktivität: Human, Ratte, Maus WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 1 (BRCA1) (AA 229-335) antibodyBRCA1 Reaktivität: Human IHC, ELISA Wirt: Maus Monoclonal 6C6D2 unconjugated
anti-Breast Cancer 1 (BRCA1) (AA 400-699) antibodyBRCA1 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 1 (BRCA1) (AA 1661-1863) antibodyBRCA1 Reaktivität: Human, Ratte, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 1 (BRCA1) (Ser184) antibodyBRCA1 Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 1 (BRCA1) (Ser184), (Ser186) antibodyBRCA1 Reaktivität: Human, Ratte WB, IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 1 (BRCA1) (AA 445-620) antibodyBRCA1 Reaktivität: Human IHC, ISt, StM Wirt: Maus Monoclonal BRCA1-1398 unconjugated
anti-Breast Cancer 1 (BRCA1) (AA 400-699) antibodyBRCA1 Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
FC(1 μg/ 10^6 cells) IF(1:100) IP(1:10 - 1:500) WB(2 - 4 μg/mL) - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 2.76 mg/mL
- Buffer
- , Sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C/-80 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
-
- Target
- BRCA1 (Breast Cancer 1 (BRCA1))
- Andere Bezeichnung
- Breast Cancer Type 1 Susceptibility Protein (BRCA1 Produkte)
- Synonyme
- BRCAI antikoerper, BRCC1 antikoerper, BROVCA1 antikoerper, IRIS antikoerper, PNCA4 antikoerper, PPP1R53 antikoerper, PSCP antikoerper, RNF53 antikoerper, iris antikoerper, pscp antikoerper, brcai antikoerper, brcc1 antikoerper, rnf53 antikoerper, brca1 antikoerper, BRCA1 antikoerper, LOC100224649 antikoerper, BRCA1, DNA repair associated antikoerper, breast cancer 1 antikoerper, breast cancer 1, early onset antikoerper, breast cancer 1 L homeolog antikoerper, BRCA1 antikoerper, brca1 antikoerper, LOC755086 antikoerper, Brca1 antikoerper, brca1.L antikoerper
- Gen-ID
- 672
- UniProt
- P38398
- Pathways
- Zellzyklus, DNA Reparatur, Intracellular Steroid Hormone Receptor Signaling Pathway, Positive Regulation of Response to DNA Damage Stimulus
-
